Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
Japanese Journal of Clinical Oncology|April 4, 2015
Docetaxel for platinum-refractory advanced thymic carcinomaNaohiro Watanabe, Shigeki Umemura, Seiji Niho, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2002
Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancerSeiji Niho, Yuichiro Ohe, Ryutaro Kakinuma, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|July 17, 2025
[Bronchoscopic Lung Volume Reduction for Severe Chronic Obstructive Lung Disease]Takahiro Nakajima, Takashi Inoue, Hiroaki Okutomi, et al.
Japanese Journal of Clinical Oncology|July 25, 2014
Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancerMasahiro Morise, Seiji Niho, Shigeki Umemura, et al.
Clinical Lung Cancer|March 6, 2016
Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR MutationsYoshitaka Zenke, Kiyotaka Yoh, Shingo Matsumoto, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2015
RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutationTatsuya Yoshida, Kiyotaka Yoh, Seiji Niho, et al.
Internal Medicine (Tokyo, Japan)|February 18, 2011
Development of Cushing's syndrome during effective chemotherapy for small cell lung cancerKoichi Suyama, Yoichi Naito, Kiyotaka Yoh, et al.
Japanese Journal of Clinical Oncology|April 7, 2004
Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancerSeiji Niho, Yuichiro Ohe, Koichi Goto, et al.
Annals of Surgical Oncology|September 13, 2022
S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II TrialKazuya Takamochi, Masahiro Tsuboi, Morihito Okada, et al.
Cancer|September 10, 2008
Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapyYoung Hak Kim, Koichi Goto, Kiyotaka Yoh, et al.
Pageof 17